British Heart Foundation

What it is

The British Heart Foundation (charity number 225971) is a UK research charity registered in 1963. Its stated vision is “a world where everyone has a healthier heart for longer,” and it positions itself as the biggest independent funder of research into cardiovascular disease in the UK.³ Heart and circulatory disease remains the world’s leading cause of death, which is the case the charity makes for its existence.

This is a research funder first and a service provider second. If you give to BHF, you are mostly buying science, plus the public-health information and support that surround it.

Where the money actually goes

The latest filed accounts cover the year ending 31 March 2025. Total income was £410.6m and total expenditure was £427.1m, so the charity spent £16.5m more than it raised in that year.¹ A single-year deficit at a charity this size is not alarming on its own (it often reflects deliberate use of reserves or timing of research commitments), but it is worth noting rather than glossing over.

The income mix is the headline. Of that £410.6m, £237.5m came from other trading activities, mostly the charity-shop estate, while £162.3m came from donations and legacies and £10.0m from investments.¹ Legacies alone were £108.4m. In plain terms: more than half of BHF’s money is earned through retail rather than donated.

On the spending side, grants to institutions were £98.6m and other charitable activity spending brought the charitable total higher.¹ That grant figure tracks with BHF’s own claim that it funds around £100 million of research a year.² Raising funds cost £47.2m and governance just £0.5m.

Effectiveness

For a UK donor whose goal is cardiovascular research, BHF is the obvious institutional vehicle. Its scale, six decades of grant-making, and concentration on a single high-burden disease area mean a donation plausibly reaches well-run research it would be hard for an individual to fund directly.²

The honest caveat is the retail model. A shop estate that turns donated goods into £237.5m of income is a real asset, but it is lower-margin than cash giving and carries staff, property, and logistics costs. The 4,545 employees and 20,000 volunteers reflect an organisation that runs a lot of operations, not just a grant desk.¹ None of this is a problem; it is simply the difference between a research charity that also runs a retail business and a lean cash-transfer programme.

The bottom line

A well-governed, on-time-reporting charity doing exactly what it says: funding the lion’s share of independent heart research in the UK. The deficit year and the retail-heavy income mix are reasons to look closely, not reasons to walk away. If you want UK medical research, give with confidence. If your test is global lives saved per pound, weigh it against the global-health options below.